Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Phys Chem C Nanomater Interfaces ; 126(2): 986-996, 2022 Jan 20.
Article in English | MEDLINE | ID: mdl-35087608

ABSTRACT

Semiconductor superstructures made from assembled and epitaxially connected colloidal nanocrystals (NCs) hold promise for crystalline solids with atomic and nanoscale periodicity, whereby the band structure can be tuned by the geometry. The formation of especially the honeycomb superstructure on a liquid substrate is far from understood and suffers from weak replicability. Here, we introduce 1,4-butanediol as an unreactive substrate component, which is mixed with reactive ethylene glycol to tune for optimal reactivity. It shows us that the honeycomb superlattice has a NC precursor state before oriented attachment occurs, in the form of a self-assembled hexagonal bilayer. We propose that the difference between the formation of the square or honeycomb superstructure occurs during the self-assembly phase. To form a honeycomb superstructure, it is crucial to stabilize the hexagonal bilayer in the presence of solvent-mediated repulsion. In contrast, a square superstructure benefits from the contraction of a hexagonal monolayer due to the absence of a solvent. A second experiment shows the very last stage of the process, where the increasing alignment of NCs is quantified using selected-area electron diffraction (SAED). The combination of transmission electron microscopy (TEM), SAED, and tomography used in these experiments shows that the (100)/(100) facet-to-facet attraction is the main driving force for NC alignment and attachment. These findings are validated by coarse-grained molecular dynamic simulations, where we show that an optimal NC repulsion is crucial to create the honeycomb superstructure.

2.
Environ Sci Technol ; 54(8): 4781-4789, 2020 04 21.
Article in English | MEDLINE | ID: mdl-32227881

ABSTRACT

Oxalic acid and sulfate salts are major components of aerosol particles. Here, we explore the potential for their respective precursor species, glyoxal and SO2, to form atmospheric brown carbon via aqueous-phase reactions in a series of bulk aqueous and flow chamber aerosol experiments. In bulk aqueous solutions, UV- and visible-light-absorbing products are observed at pH 3-4 and 5-6, respectively, with small but detectable yields of hydroxyquinone and polyketone products formed, especially at pH 6. Hydroxymethanesulfonate (HMS), C2, and C3 sulfonates are major products detected by electrospray ionization mass spectrometry (ESI-MS) at pH 5. Past studies have assumed that the reaction of formaldehyde and sulfite was the only atmospheric source of HMS. In flow chamber experiments involving sulfite aerosol and gas-phase glyoxal with only 1 min residence times, significant aerosol growth is observed. Rapid brown carbon formation is seen with aqueous aerosol particles at >80% relative humidity (RH). Brown carbon formation slows at 50-60% RH and when the aerosol particles are acidified with sulfuric acid but stops entirely only under dry conditions. This chemistry may therefore contribute to brown carbon production in cloud-processed pollution plumes as oxidizing volatile organic compounds (VOCs) interact with SO2 and water.


Subject(s)
Carbon , Glyoxal , Aerosols , Spectrometry, Mass, Electrospray Ionization , Water
3.
Biol Trace Elem Res ; 126(1-3): 49-55, 2008.
Article in English | MEDLINE | ID: mdl-18685814

ABSTRACT

Arsenical compounds are known to interfere with normal thyroid function. Therefore, we designed an experiment to determine the minimal concentration of arsenic trioxide (As2O3) required to inhibit thyroid peroxidase (TPO) activity in vitro. The activity of commercially prepared human TPO was assayed spectrophotometrically in the absence (control) or presence of arsenic (0.1, 1.0, 5.0, and 10 ppm) during a 10-min incubation period. The results of this study indicate a significant dose-response relationship with the highest concentration of arsenic producing the greatest amount of TPO inhibition. Compared to controls, 0.1 ppm arsenic had no effect on TPO activity. Incubation for 2 min in the presence of 1.0, 5.0, or 10 ppm arsenic inhibited TPO activity to 4%, 9%, and 9% of control, respectively. After 10 min incubation in the presence of 1.0 or 5.0 ppm arsenic, TPO activity returned to 92% and 54% of control, respectively, while the presence of 10 ppm arsenic further inhibited TPO activity to 1% of control. In summary, arsenic trioxide inhibits in vitro TPO activity in a dose-dependent manner, and the minimal dose required to inhibit this activity is between 0.1 and 1 ppm.


Subject(s)
Arsenicals/pharmacology , Iodide Peroxidase/antagonists & inhibitors , Oxides/pharmacology , Arsenic Trioxide , Dose-Response Relationship, Drug , Humans , Iodide Peroxidase/metabolism
4.
Nephrology (Carlton) ; 8(5): 239-42, 2003 Oct.
Article in English | MEDLINE | ID: mdl-15012710

ABSTRACT

Theophylline is commonly used in the treatment of bronchospastic lung disease. In addition to gastrointestinal and cardiac dysfunction, hypokalaemia, lactic and ketoacidosis can complicate theophylline overdose. Clinicians frequently fail to identify theophylline's role when complications develop. A case of an 80-year-old man who developed profound metabolic disturbances while hospitalized is presented. The typical causes of these abnormalities were absent, theophylline levels were elevated, and the patient recovered after theophylline was held. Based on our case and review of the literature, we discuss the reasons why theophylline toxicity is under-recognized, and propose mechanisms for the rare metabolic abnormalities identified in this case. A high index of suspicion for theophylline toxicity should be maintained and it should be considered when unexplained acidosis or hypokalaemia occur.


Subject(s)
Acidosis, Lactic/chemically induced , Hypokalemia/chemically induced , Ketosis/chemically induced , Phosphodiesterase Inhibitors/toxicity , Theophylline/toxicity , Acidosis, Lactic/metabolism , Acidosis, Lactic/therapy , Aged, 80 and over , Bicarbonates/blood , Carbon Dioxide/blood , Humans , Hypokalemia/metabolism , Hypokalemia/therapy , Ketosis/metabolism , Ketosis/therapy , Male , Oxygen/blood , Phosphodiesterase Inhibitors/blood , Poisoning/diagnosis , Poisoning/metabolism , Poisoning/therapy , Theophylline/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...